Single Dose Safety, Tolerability And Pharmacokinetics Of Escalating Intravenous Doses Of Linezolid Followed By Evaluation Of The Effect Of Single Intravenous Doses Of Linezolid On QTc Interval In Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 17 May 2010
At a glance
- Drugs Linezolid; Moxifloxacin
- Indications Bacterial infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Pfizer
- 10 Apr 2010 Results assessing QT interval prolongation presented at the 20th European Congress of Clinical Microbiology and Infectious Diseases.
- 08 Apr 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Apr 2009 Actual initiation date changed from Jan 2009 to Dec 2008 as reported by ClinicalTrials.gov.